Transgenic TCR-T Cell Therapies for Solid Tumors: Mechanisms of

Treatment Success, Acquired Resistance and Reverse-Engineering

Next-Generation Cell Therapies

Theodore Nowicki, MD, PhD

Assistant Professor-in-Residence, Pediatric Hematology/Oncology,

David Geffen School of Medicine at UCLA

Zoom Meeting ID – 92751691624;   Password – CDI2025

Contact – Nancy Tadros – ntadros@mednet.ucla.edu